What’s Crazier: The SEC or the True Story of the Death of

New Post Public Reply Private Reply Replies (0) Message Board
AlanC
215
What’s Crazier: The SEC or the True Story of the Death of James Foley?

September 16, 2019 2 min read

News from the grassroots of Wall Street has been reaching me. An old friend from Staten Island, who seems to be wired into most scuttlebutt on Wall Street, tells me that a broker or two is telling OSTK shorts that they need not worry about the upcoming dividend, because the SEC is going to step in and save their bacon. Every component of what Overstock is doing has already passed the SEC sniff test (I worked at Overstock once, have left the firm and have no relationship with it now, but those are the hoops through which I carefully jumped these last couple of years).

Overstock has over its lifetime issued 37 million shares of OSTK, it is generating 3.7 million blockchain-based tokens to trade on tZERO, and issuing them on a 1 for 10 basis. The arithmetic works for most of us, I think. I am pretty sure I could teach my dog to follow it, but some on Wall Street object that this is manipulative. Really, they do. That’s what they say.

So this is going to give us a chance to find out whether Wall Street players are still above the law if they “have juice” (as was once said within the SEC about Morgan Stanley CEO John Mack, when an investigator named Gary Aguirre was told to lay off him, because in the pre-2008 days the SEC was captured by powerful Wall Street interests).

The truth is, of course, it disturbs them because the settlement system is as sloppy as I say, no one knows who owns how much, a blockchain-based dividend reveals and fixes all the slop, and the oligarchy (which derives so much wealth in so many different ways from the fact of that slop), neither wants it revealed nor fixed. They cannot say that, so I am sure they will try to rationalize it in a dozen different ways, but look up the Dole case (“Dole Case Illustrates Problems in Shareholder System” New York Times March 2017 ) or read around on this site and it will all become clear.

The SEC exists to protect investors. No retail investor would lose a penny from that dividend going forward. The only market participants in harm’s way would be the shorts, but shorts are sophisticated investors. They were notified months ago in an 8K that this was happening. They took the risk anyway. If the SEC responds to the lobbying they are getting from their client industry (Wall Street), if the SEC steps in and disrupts this perfectly fair and appropriate dividend from OSTK, it will be the single greatest piece of proof one could imagine that they are still in the pocket of the oligarchy. And I, who have tried these last few years to help them rebuild their reputation with the public, will be … unhappy.

It reminds me in some odd way of the true story of the death of James Foley. I thought that was one of the wackiest stories I ever knew, and I have felt no small amount of guilt keeping the truth secret as I have, but even that angst would be topped by this one, were the SEC to interfere so openly with the proper functioning of the market in order to advantage concentrated interests by imposing a dispersed cost on the retail investing public.

What would be the right thing to do? It has been weighing on my conscience a lot of late: you know, even in my recent and now publicly-disclosed whistleblowing, I never breathed a word of Foley to anyone. Not even the current and legitimate feds. I am not sure if withholding the truth from his family and the authorities is correct of me. Let me know your thoughts in the comment section.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Pinnacol’s Community Work Earns Denver Chamber Recognition

Updated Category News Views 67

A workers’ comp insurer usually becomes visible on somebody’s worst day; Pinnacol Assurance is being recognized for the work it keeps doing around those days. The Denver Metro Chamber of Commerce has given the Colorado-based, member-owned carrier its 2026 Business Impact Award for Corporate Social Responsibility. Awards can be cheap applause, frankly. This one...

Continue Reading
CVRx Lawsuit Puts a Hard Date on Investor Decisions

Updated Category News Views 65

One ugly filing after the bell can vaporize years of shareholder confidence, and CVRx just supplied the painful exhibit. On August 7, 2026, shares of CVRx fell $3.55, or 59.76%, to close at $2.39 after the company disclosed a U.S. Department of Justice civil investigative demand in its August 6 Form 10-Q. That is not a routine bad quarter. It is the sort of disclosure...

Continue Reading
Lymphatic Research Gains Attention Beyond Wellness Claims

Updated Category News Views 23

Ankles leave little clues after a long day: sock grooves, puffiness, that dull heaviness nobody bothers to name. PureHealth Research wants people to look past the usual salt-and-water explanation and consider the lymphatic system, the body’s comparatively unsung network for gathering fluid from tissues and returning it to the bloodstream. Fair enough. This system does...

Continue Reading
Tigerlily Brings HIV Information to Women’s Health

Updated Category News Views 99

A stubborn information gap is exactly where Tigerlily Foundation is planting its flag. The nonprofit’s new national HIV education and awareness campaign, THE POWER OF U, expands work that began in breast cancer advocacy into another area where women need clear facts, trusted voices, and room to speak without being shamed for needing answers. This is not a story that...

Continue Reading
ASA’s 2026 Grants Push Dermatology Into New Terrain

Updated Category News Views 104

Thirteen Small Bets With Serious Human Stakes Skin science rarely gets the splashy headlines, yet it touches a staggering number of people and carries some very stubborn unanswered questions. American Skin Association’s 2026 grant class puts 13 awards across skin cancer and dermatologic disease, with a noticeable willingness to follow newer clinical terrain rather than...

Continue Reading
Protein Now! Gains Clinician Attention, With Caveats

Updated Category News Views 91

A Small Bottle Has Drawn a Crowd Protein powder tubs have been cluttering kitchens for years; a 3.38-fluid-ounce shot is a cleaner answer to the same daily hassle. NutraBio Labs says more than 800 physicians, nurse practitioners, and physician associates had added PROTEIN NOW! to their individual FrontrowMD patient pages as of November 2026. That earned the product a...

Continue Reading
Fluence Investors Face a November 27 Litigation Clock

Updated Category News Views 14

Six calendar squares are all that separate eligible Fluence investors from the November 27, 2026 lead-plaintiff deadline. That is not much time to locate trade confirmations, calculate losses, and decide whether taking a larger role in a securities case makes sense. The lawsuit is not a verdict, and anybody pretending otherwise is selling smoke. But the underlying...

Continue Reading
Africa Tech Festival Puts Trust Ahead of AI Hype Cycle

Updated Category News Views 75

Fifteen thousand people can fill a convention centre, but they cannot magically deliver a package, fund a small business, or repair harm from a bad automated decision. That rather useful dose of reality ran through the final day of Africa Tech Festival 2026 in Cape Town. The 29th edition drew more than 15,000 delegates across three days, and the strongest message was not...

Continue Reading
Epiroc Takes Live Remote Drilling to CES 2027 Stage

Updated Category News Views 48

A drill rig chewing through Virginia rock from a Las Vegas convention booth is either a serious industrial-tech moment or an expensive magic trick. At CES 2027, Epiroc intends to make the distinction painfully clear. From January 6 through 9, the Stockholm-based mining-equipment company and Luck Stone will connect Booth 7031 in the LVCC West Hall to a working quarry in...

Continue Reading
Healthcare's Prevention Puzzle Needs Better Incentives

Updated Category News Views 113

When Savings Belong to the Next Plan A patient changing insurance plans can turn prevention into nobody’s asset. That is the uncomfortable little engine inside Russell Greenfield’s recent argument: an insurer may pay today for a program that helps prevent chronic illness, only to watch the eventual savings land with another plan after the member moves on. The person...

Continue Reading

Top 5 Most Recently Viewed Articles

ICG Enterprise Trust plc Announces Share Repurchase Details

Updated Category News Views 159

ICG Enterprise Trust plc Share Buyback Announcement ICG Enterprise Trust plc (the “Company”) The Company has announced a recent development regarding its share buyback initiative. On a significant date, it repurchased 15,000 of its own shares aimed to be held as treasury shares, with each share valued at an average price of 1450 pence. Details of the Transaction...

Continue Reading
Converge Technology Solutions Shares Third Quarter 2024 Insights

Updated Category News Views 217

Converge Technology Solutions Announces Preliminary Q3 Results Converge Technology Solutions Corp. (CTS) has released its preliminary unaudited financial results for the third quarter of 2024. The company is committed to delivering insightful updates to its stakeholders as part of its transparency approach. The company stated that all figures are presented in Canadian...

Continue Reading
Discovery Silver Corp. Unveils 2023 ESG Report

Updated Category News Views 104

Discovery Silver Corp. Releases 2023 ESG Report Key Highlights: Earned Quality Environmental Certification from the Mexican Government Recognized as a Socially Responsible Enterprise by the Mexican Center for Philanthropy Achieved Great Place to Work Certification Discovery Silver Corp. (TSX: DSV, OTCQX: DSVSF) is excited to announce the publication of its 2023...

Continue Reading
Final Call for Subscription in IDEX Biometrics Offering Today

Updated Category News Views 152

Important Subscription Period Details for IDEX Biometrics Today marks a significant turning point for IDEX Biometrics ASA as the subscription period for their subsequent offering of shares closes. The company previously announced that they aim to issue up to 600 million new shares at a remarkable subscription price of NOK 0.01 per share. This offering, essential for...

Continue Reading
Dundee Corporation Strengthens Position in Greenheart Gold Inc.

Updated Category News Views 33

Overview of Recent Acquisition Dundee Corporation (TSX: DC.A) has announced that its wholly-owned subsidiary, Dundee Resources Limited, recently acquired 2,000,000 common shares of Greenheart Gold Inc. (TSXV: GHRT) at a price of C$0.50 per share, totaling an investment of C$1,000,000. This acquisition is part of the Issuer's bought deal private placement and signifies...

Continue Reading